These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 10454778

  • 1. Treatment practices of FSGS among North American pediatric nephrologists.
    Vehaskari VM.
    Pediatr Nephrol; 1999 May; 13(4):301-3. PubMed ID: 10454778
    [Abstract] [Full Text] [Related]

  • 2. Treatment of steroid-resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents.
    Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, Tune BM.
    Pediatr Nephrol; 1990 Jul; 4(4):303-7. PubMed ID: 2206894
    [Abstract] [Full Text] [Related]

  • 3. Cyclosporine in the treatment of idiopathic focal segmental glomerulosclerosis.
    Cattran DC.
    Semin Nephrol; 2003 Mar; 23(2):234-41. PubMed ID: 12704584
    [Abstract] [Full Text] [Related]

  • 4. Combination of pulse methylprednisolone infusions with cyclosporine-based immunosuppression is safe and effective to treat recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
    Shishido S, Satou H, Muramatsu M, Hamasaki Y, Ishikura K, Hataya H, Honda M, Asanuma H, Aikawa A.
    Clin Transplant; 2013 Mar; 27(2):E143-50. PubMed ID: 23383697
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis.
    Korbet SM.
    Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582
    [Abstract] [Full Text] [Related]

  • 6. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.
    Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL.
    Kidney Int; 1999 Dec; 56(6):2220-6. PubMed ID: 10594798
    [Abstract] [Full Text] [Related]

  • 7. Rapamycin for focal segmental glomerulosclerosis: a report of 3 cases.
    Tsagalis G, Psimenou E, Iliadis A, Nakopoulou L, Laggouranis A.
    Am J Kidney Dis; 2009 Aug; 54(2):340-4. PubMed ID: 19303679
    [Abstract] [Full Text] [Related]

  • 8. Treatment of childhood nephrotic syndrome.
    Mendoza SA, Tune BM.
    J Am Soc Nephrol; 1992 Oct; 3(4):889-94. PubMed ID: 1450365
    [Abstract] [Full Text] [Related]

  • 9. Pulse cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis.
    Rennert WP, Kala UK, Jacobs D, Goetsch S, Verhaart S.
    Pediatr Nephrol; 1999 Feb; 13(2):113-6. PubMed ID: 10228995
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 11. Pediatric steroid-resistant nephrotic syndrome.
    McBryde KD, Kershaw DB, Smoyer WE.
    Curr Probl Pediatr Adolesc Health Care; 2001 Oct; 31(9):280-307. PubMed ID: 11733743
    [No Abstract] [Full Text] [Related]

  • 12. Pulse methylprednisolone, cyclosporine, and ace inhibitor therapy decreases proteinuria in two siblings with familial focal segmental glomerulosclerosis.
    Yorgin PD, Belson A, Higgins J, Alexander SR.
    Am J Kidney Dis; 2001 Jun; 37(6):E44. PubMed ID: 11382715
    [Abstract] [Full Text] [Related]

  • 13. Treatment of focal segmental glomerulosclerosis.
    Meyrier A.
    Expert Opin Pharmacother; 2005 Aug; 6(9):1539-49. PubMed ID: 16086641
    [Abstract] [Full Text] [Related]

  • 14. Treatment of focal segmental glomerulosclerosis.
    Matalon A, Valeri A, Appel GB.
    Semin Nephrol; 2000 May; 20(3):309-17. PubMed ID: 10855941
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of steroids, cyclosporin and cyclophos-phamide in steroid resistant idiopathic nephrotic syndrome.
    Hafeez F, Ahmad TM, Anwar S.
    J Coll Physicians Surg Pak; 2005 Jun; 15(6):329-32. PubMed ID: 15924835
    [Abstract] [Full Text] [Related]

  • 16. Primum non nocere: Should adults with idiopathic FSGS receive steroids?
    Franceschini N, Hogan SL, Falk RJ.
    Semin Nephrol; 2003 Mar; 23(2):229-33. PubMed ID: 12704583
    [Abstract] [Full Text] [Related]

  • 17. Plasmapheresis-induced remission in otherwise therapy-resistant FSGS.
    Vécsei AK, Müller T, Schratzberger EC, Kircher K, Regele H, Arbeiter K, Schroth B, Aufricht C.
    Pediatr Nephrol; 2001 Nov; 16(11):898-900. PubMed ID: 11685597
    [Abstract] [Full Text] [Related]

  • 18. Intravenous pulse cyclophosphamide therapy in focal segmental glomerulosclerosis.
    Buyukcelik M, Cengiz N, Dursun H, Soran M, Bayazit AK, Noyan A, Anarat A.
    Clin Nephrol; 2006 Jan; 65(1):7-12. PubMed ID: 16429836
    [Abstract] [Full Text] [Related]

  • 19. Secondary resistance to cyclosporin A in children with nephrotic syndrome.
    Sairam VK, Kalia A, Rajaraman S, Travis LB.
    Pediatr Nephrol; 2002 Oct; 17(10):842-6. PubMed ID: 12376814
    [Abstract] [Full Text] [Related]

  • 20. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus.
    Bhimma R, Adhikari M, Asharam K, Connolly C.
    Am J Nephrol; 2006 Oct; 26(6):544-51. PubMed ID: 17159342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.